{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T09:24:21Z","timestamp":1787131461139,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007338","name":"All-India Institute of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijmmb.2026.101174","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:30:44Z","timestamp":1781566244000},"page":"101174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Decoding moxifloxacin resistance in pre-XDR tuberculosis using MGIT 960 and MYCOTB AST"],"prefix":"10.1016","volume":"62","author":[{"given":"D","family":"Daniel Raj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4827-919X","authenticated-orcid":false,"given":"Anand Kumar","family":"Maurya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashank","family":"Purwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Khadanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alkesh Kumar","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sowmya","family":"Dhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasis","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijmmb.2026.101174_bib1","doi-asserted-by":"crossref","first-page":"e00409","DOI":"10.1128\/Spectrum.00409-21","article-title":"Strong increase in moxifloxacin resistance rate among multidrug-resistant Mycobacterium tuberculosis isolates in China, 2007 to 2013","volume":"9","author":"Xia","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijmmb.2026.101174_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.938032","article-title":"Fluoroquinolone heteroresistance, antimicrobial tolerance, and lethality enhancement","volume":"12","author":"Singh","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.ijmmb.2026.101174_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01829-21","article-title":"Clinical relevance of Rifampicin\u2010Moxifloxacin interaction in Isoniazid-Resistant\/Intolerant tuberculosis patients","volume":"66","author":"Vogensen","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijmmb.2026.101174_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2023.102340","article-title":"Evolution of tuberculosis diagnostics: from molecular strategies to nanodiagnostics","volume":"140","author":"Mukherjee","year":"2023","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ijmmb.2026.101174_bib5","series-title":"Global Tuberculosis report","year":"2025"},{"issue":"11","key":"10.1016\/j.ijmmb.2026.101174_bib7","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/jcph.968","article-title":"A review of moxifloxacin for the treatment of drug\u2010susceptible tuberculosis","volume":"57","author":"Naidoo","year":"2017","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.ijmmb.2026.101174_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4103\/0974-777X.157237","article-title":"Utility of line probe assay for the early detection of multidrug-resistant pulmonary tuberculosis","volume":"7","author":"Madhuri","year":"2015","journal-title":"J Global Infect Dis"},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101174_bib10","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1038\/s41598-018-27299-z","article-title":"Association of gyrA and rrs gene mutations detected by MTBDRsl V1 on Mycobacterium tuberculosis strains of diverse genetic background from India","volume":"8","author":"Rufai","year":"2018","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.ijmmb.2026.101174_bib11","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1128\/JCM.02048-12","article-title":"Evaluation of the sensititre MycoTB plate for susceptibility testing of the Mycobacterium tuberculosis complex against First- and second-line agents","volume":"50","author":"Hall","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101174_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/AAC.01209-13","article-title":"Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to First- and second-line drugs","volume":"58","author":"Lee","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijmmb.2026.101174_bib13","unstructured":"Technical manual for drug susceptibility testing of medicines used in the treatment of tuberculosis. Licence: CC BY-NC-SA 3.0 IGO. [cited 2026 Jan 13]. Available from: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/32a3a2b3-a367-4370-81fe-7c48f9b44773\/content."},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101174_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169413","article-title":"Assessment of a 96-Well plate assay of quantitative drug susceptibility testing for Mycobacterium Tuberculosis complex in China. Yam WC","volume":"12","author":"Xia","year":"2017","journal-title":"PLoS One"},{"issue":"25","key":"10.1016\/j.ijmmb.2026.101174_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020648","article-title":"Meta-analysis on effectiveness and safety of moxifloxacin in treatment of multidrug resistant tuberculosis in adults","volume":"99","author":"Guan","year":"2020","journal-title":"Medicine (Baltim)"},{"issue":"3","key":"10.1016\/j.ijmmb.2026.101174_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab660","article-title":"Model-Based efficacy and toxicity comparisons of moxifloxacin for multidrug-resistant tuberculosis","volume":"9","author":"Yun","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.ijmmb.2026.101174_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02533-20","article-title":"Dose fractionation of moxifloxacin for treatment of tuberculosis: impact of dosing interval and elimination half-life on microbial kill and resistance suppression","volume":"65","author":"Drusano","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.ijmmb.2026.101174_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167093","article-title":"A comparison of the sensititre MycoTB plate, the bactec MGIT 960, and a microarray-based molecular assay for the detection of drug resistance in clinical Mycobacterium tuberculosis isolates in Moscow, Russia. Mokrousov I","volume":"11","author":"Nosova","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ijmmb.2026.101174_bib19","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.5588\/ijtld.15.0896","article-title":"Comparison of TaqMan\u00ae Array Card and MYCOTBTM with conventional phenotypic susceptibility testing in MDR-TB","volume":"20","author":"Foongladda","year":"2016","journal-title":"Int J Tubercul Lung Dis"},{"issue":"2","key":"10.1016\/j.ijmmb.2026.101174_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5578\/mb.66683","article-title":"Comparison of two methods for the detection of antituberculous drug susceptibility in Mycobacterium tuberculosis complex isolates: sensititre MycoTB MIC plate and the indirect agar proportion methods","volume":"2018","author":"Varici Balci","year":"2018","journal-title":"Mikrobiyoloji Bulteni"},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101174_bib21","doi-asserted-by":"crossref","DOI":"10.4102\/ajlm.v8i1.840","article-title":"Resazurin microtitre plate assay and sensititre\u00ae MycoTB for detection of Mycobacterium tuberculosis resistance in a high tuberculosis resistance setting","volume":"8","author":"Jaglal","year":"2019","journal-title":"Afr J Lab Med"},{"issue":"2","key":"10.1016\/j.ijmmb.2026.101174_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5578\/mb.69226","article-title":"Rifampisine diren\u00e7li Mycobacterium tuberculosis kompleks \u0130zolatlar\u0131n\u0131n antit\u00fcberk\u00fcloz \u0130la\u00e7 duyarl\u0131l\u0131\u011f\u0131 \u0130\u00e7in sensititre MycoTB plak Y\u00f6nteminin Kullan\u0131lmas\u0131","volume":"54","author":"Ceyhan","year":"2020","journal-title":"Mikrobiyoloji Bulteni"},{"issue":"11","key":"10.1016\/j.ijmmb.2026.101174_bib23","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1128\/AAC.01117-15","article-title":"Sensititre MycoTB plate compared to bactec MGIT 960 for First- and second-line antituberculosis drug susceptibility testing in Tanzania: a call to operationalize MICs","volume":"59","author":"Heysell","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ijmmb.2026.101174_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5588\/ijtld.15.0573","article-title":"Sensititre\u00ae MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates","volume":"20","author":"Yu","year":"2016","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.ijmmb.2026.101174_bib25","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ejmech.2019.07.057","article-title":"Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains","volume":"180","author":"Gao","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ijmmb.2026.101174_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124740","article-title":"Development of inhaled moxifloxacin-metformin formulation as an alternative for pulmonary tuberculosis treatment","volume":"666","author":"Simon","year":"2024","journal-title":"Int J Pharm"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085726001325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085726001325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:28:43Z","timestamp":1787128123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085726001325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":24,"alternative-id":["S0255085726001325"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmmb.2026.101174","relation":{},"ISSN":["0255-0857"],"issn-type":[{"value":"0255-0857","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding moxifloxacin resistance in pre-XDR tuberculosis using MGIT 960 and MYCOTB AST","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmmb.2026.101174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101174"}}